Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0208)

Hamilton, Ontario L8V 5C2

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Biliary Tract Cancers, Colorectal Cancer, Diffuse Large B-Cell Lymphoma, Gastric Cancer, Glioblastoma, Ovarian Cancer, Pancreatic Cancer, Triple Negative Breast Cancer

Studies at this site

• A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) — Recruiting now
• Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) — Completed